Status:
COMPLETED
The Clinical Utility of Extracorporeal Shock Wave Therapy on Burns
Lead Sponsor:
Hangang Sacred Heart Hospital
Conditions:
Burn Scar
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
In burn patients, the wound healing process may lead to a fibrotic hypertrophic scar, which is raised, inflexible and responsible functional impairments. There are few studies which have investigated ...
Detailed Description
In burn patients, the wound healing process may lead to a fibrotic hypertrophic scar, which is raised, inflexible and responsible functional impairments. There are few studies which have investigated ...
Eligibility Criteria
Inclusion
- aged ≥18 years
- deep partial-thickness (second-degree) burn or a full thickness (third-degree) burn
- less than 6 months since the onset of the burn injury
Exclusion
- history of cancer
- fourth-degree burns (involving muscles, tendons, and bone injuries)
- musculoskeletal diseases (fracture, amputation, rheumatoid arthritis, and degenerative joint diseases)
- pregnancy
- if there was potential for additional damage to the skin due to the use of ESWT and conventional occupational therapy
Key Trial Info
Start Date :
April 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04340271
Start Date
April 15 2020
End Date
May 31 2020
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hangang Sacred Heart Hospital
Seoul, Yeong-deungpo-Dong, South Korea, 150-719